New Uncertainty In Subject Matter Eligibility For Biopharma Products

Financier Worldwide Magazine
July 2012

This article addresses the Supreme Court’s 9-0 Prometheus decision that certain personalized medicine tests lack subject matter eligibility and are unpatentable laws of nature.

View Attachment (PDF)